Indeed, β3-AR antagonism on tumor-infiltrating lymphocytes (TILs) reduced their ability to produce IFN-γ, which reduced the expression of PD-L1 provoked by TILs infiltration into NB tumor cells. Here, ADRB3 is linked to neoplasm.